week-in-review-544x310

Real Estate Articles of Note
April 6 – April 12, 2019

The following represents articles of interest to the Boston real estate community that appeared in various publications during the week. Certain news links may require site registration or subscription to access the complete article.

 

 

Life Science Landlord Invests in Startup Tenants
Banker & Tradesman — April 12, 2019
One of the largest developers of life science space in Cambridge and the U.S., Alexandria Real Estate Equities, is investing directly in its tenants through its Alexandria Seed Capital Platform.

 

Empty store space in Downtown Crossing may become offices
BostonGlobe.com — April 12, 2019
One of the biggest retail spaces in Downtown Crossing may soon become home to offices.

 

Student Housing Tower Would Include Performing Arts Center
Banker & Tradesman — April 12, 2019
A London developer’s proposed private academic housing tower in the Fenway recognizes the property’s history as the home to a series of gay nightclubs, with plans that include a 120-seat LGBTQ-centric “Boylston Black Box” performing arts center.

 

Springfield Medical Portfolio Sells for $30.2M
Banker & Tradesman — April 12, 2019
A three-building Springfield medical office portfolio has changed hands for roughly $10 million per building.

 

In Newton, sparks fly over proposed Needham Street development
The Boston Globe - Print Edition — April 12, 2019
A proposed mixed-use development that could bring hundreds of new housing units divided residents during an hours-long public hearing.

 

Capital One confirms Kendall Square expansion
Boston Business Journal — April 11, 2019
McLean, Virginia-based Capital One Financial Corp. on Thursday confirmed plans to lease 78,000 square feet in Cambridge, an office that could host "several hundred" technology workers.

 

Big Investors Like Boston for the Long Haul
Banker & Tradesman — April 11, 2019
Institutional investors rate Boston as the world’s second-most desirable place to increase their real estate holdings, according to a new survey.

 

Cambridge bike-network ordinance first of its kind nationwide
Curbed Boston — April 10, 2019
Boston neighbor mandates miles of permanent, protected bike lanes connecting major parts of the city

 

While Boston Market Tightens, MetroWest Rents, Home Prices Still Affordable
Banker & Tradesman — April 10, 2019
Communities west of Boston and near Interstate 495 continue to enjoy commercial rents and home prices well below averages in the metropolitan area despite steady population growth, according to a new report.

 

Massachusetts millennials have it the best, report says
Curbed Boston — April 09, 2019
Massachusetts is the best state in the union for millennials, according to a new report.

 

A South End development project begins — in Roxbury
The Boston Globe - Print Edition — April 09, 2019
The Alexandra Hotel project has attracted interest from neighbors in both the South End and Roxbury, both equally eager to see the restoration of the once majestic building, now an eyesore due to neglect.

 

Seaport condo hits Boston price record
Boston Business Journal — April 09, 2019
Tishman Speyer’s ultra-luxury Pier 4 condominium complex has hit a price record never before seen in Boston, with two penthouse units selling at $4,180 per square foot.

 

Cambridge Lab Sale Approaches Local Record
Banker & Tradesman — April 08, 2019
An office and lab building near Harvard Square has sold for $128 million, approaching the local record price-per-square-foot for life science space in Greater Boston.

 

Regeneron to invest $800 million in Alnylam ...
STAT — April 08, 2019
Regeneron Pharmaceuticals said Monday it will pay $800 million to Alnylam, a biotechnology firm in Cambridge, Mass., to leverage its gene-silencing technique for the development of new therapies and to become its exclusive partner for new drugs focused on the central nervous system or the eye.

 

 

COLLIERS IN THE NEWS

 

A New Hand Takes the Helm at Colliers
Banker & Tradesman — April 07, 2019
An interview with David Goodhue, Executive managing director and Boston market leader, Colliers International

 

The Changing Dynamic of Class B Assets
colliersinfocus.com — April 10, 2019
The narrative around Class B is changing, but nobody’s talking about it. It seems everyone is wrapped up in the strength of the tech market and venture-backed companies, and therefore assuming Class B is the beneficiary. That logic is sound, at least if history is any guide.

 

Wilcox of Bulfinch handles 16,000 s/f lease to Candel Therapeutics on behalf of ownership
nerej.com — April 12, 2019
According to Bulfinch, Candel Therapeutics, a Massachusetts based biotechnology company, has signed a 7-year lease for 16,000 s/f of lab and office space at 117 Kendrick St.

 

Candel Therapeutics Leases 16,000 SF Office and Lab Space in Needham
Boston RE Times — April 10, 2019
Bulfinch announced that Candel Therapeutics, a Massachusetts-based biotechnology company, has signed a 7-year lease for 16,000 SF of lab and office space at 117 Kendrick Street in Needham, MA.

 

 

 

To subscribe to the Week In Review newsletter mailing list email WeekInReview@colliers.com